Unidoc Health Corp. (UDOCF) Stock Price & Analysis
Unidoc Health Corp. (UDOCF) — price $0.038 (+35.71%), as of the Nov 19, 2026 trading session; market cap $3.28M.
Educational signal · not a buy or sell recommendation · How to read this
Unidoc Health Corp. · UDOCF
UniDoc Health Corp. operates as a virtual health/telemedicine solutions company in Canada, offering customizable Virtual Health Clinics. These clinics connect patients in various locations with medical care, rapid diagnostic testing, and therapeutic treatment with health monitoring.
Price as of Nov 19, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.038 | |
| Change on the day | +35.71% | |
| 52-week range | $0.0328 – $0.17 | |
| Market capitalisation | $3.28M | — |
| Shares traded on the day | 1.0K |
Price & events
What is Unidoc Health (UDOCF), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Unidoc Health Corp. (UDOCF) is the company analyzed here. It employs 2 people and is led by Antonio Baldassarre. In Q1 FY2027 it reported revenue of C$148,397 and net income of -C$522,987. The market values it at $3.28M.
What do the latest results show for Unidoc Health (UDOCF)?
Short answer · as of
The most recent reported quarter, Q1 FY2027, carried revenue of C$148,397.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 FY2027 | C$148,397 | -C$522,987 | -C$0.01 (diluted) |
| Q4 FY2026 | C$235,760 | -C$1M | -C$0.01 (diluted) |
| Q3 FY2026 | C$238,275 | -C$610,910.7 | -C$0.01 (diluted) |
| Q2 FY2026 | C$325,006 | -C$877,010 | -C$0.01 (diluted) |
What are the financial strengths and risks for Unidoc Health (UDOCF)?
Short answer · as of
The distress and quality screens read Altman Z -24.16 · Piotroski F 2. Trailing ratios: ROE 355.6% · current ratio 0.23 · earnings yield -72.4% · free-cash-flow yield -47.7%.
Data-derived red flags
- Financial-distress signal — its Altman Z-Score of -24.16 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held UDOCF in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported UDOCF in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Unidoc Health Stock: Key Questions Answered
These answers are editorial: 1 of these 8 answers is drawn from the UDOCF research dossier (written Mar 16, 2026 by gemini-2.0-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is UDOCF a good stock to buy?
Stock Expert AI does not rate UDOCF buy, sell or hold. Unidoc Health Corp. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the UDOCF stock price today?
The last price recorded for Unidoc Health Corp. (UDOCF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What does Unidoc Health Corp. do?
UniDoc Health Corp. operates as a virtual health/telemedicine solutions company in Canada. It focuses on providing accessible healthcare through its Virtual Health Clinics, which connect patients in urban, rural, and remote locations with medical professionals.
What are the key factors to evaluate for UDOCF?
Evaluate UDOCF on fundamentals, analyst consensus, and risk factors. These partnerships can be established within the next year. Not financial advice.
How frequently does UDOCF data refresh on this page?
UDOCF's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven UDOCF's recent stock price performance?
Unidoc Health Corp. (UDOCF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Customizable Virtual Health Clinic platform. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider UDOCF overvalued or undervalued right now?
Unidoc Health Corp. (UDOCF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research UDOCF before investing?
Before investing in Unidoc Health Corp. (UDOCF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 13 figures on this page — 7 from Financial Modeling Prep (FMP) and 6 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com